HEART TRANSPLANT INFECTION
Clinical trials for HEART TRANSPLANT INFECTION explained in plain language.
Never miss a new study
Get alerted when new HEART TRANSPLANT INFECTION trials appear
Sign up with your email to follow new studies for HEART TRANSPLANT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a thyroid hormone boost heart transplant success?
Disease control Recruiting nowThis trial tests whether giving levothyroxine, a thyroid hormone, right after a heart transplant helps the new heart work better and reduces complications. Adults listed for heart transplant will be randomly assigned to receive levothyroxine or a placebo (saline) during the first…
Matched conditions: HEART TRANSPLANT INFECTION
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Heart transplant patients may get safer virus protection
Disease control Recruiting nowThis study tests whether a newer drug, letermovir, is safer and more effective than the standard valganciclovir for preventing CMV infection in heart transplant recipients. About 150 moderate- to high-risk adults will be enrolled. The main focus is on reducing side effects like l…
Matched conditions: HEART TRANSPLANT INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC